European Journal of Cancer
Volume 46, Issue 4 , Pages 765-781 , March 2010

Estimates of cancer incidence and mortality in Europe in 2008

  • J. Ferlay

      Affiliations

    • International Agency for Research on Cancer, 150 Cours Albert Thomas, 69372 Lyon Cedex 08, France
    • Corresponding Author InformationCorresponding author: Tel.: +33 4 72 73 84 90; fax: +33 4 72 73 80 22.
    • ,
  • D.M. Parkin

      Affiliations

    • Clinical Trial Service Unit and Epidemiological Studies Unit, University of Oxford, Oxford OX3 7LF, UK
    • ,
  • E. Steliarova-Foucher

      Affiliations

    • International Agency for Research on Cancer, 150 Cours Albert Thomas, 69372 Lyon Cedex 08, France

Received 23 October 2009 ,Revised 2 December 2009 ,Accepted 4 December 2009.

References 

  1. Parkin DM. The evolution of the population-based cancer registry. Nat Rev Cancer. 2006;6(8):603–612
  2. World Health Organization. National cancer control programmes. Policies and managerial guidelines. 2nd ed. Geneva: WHO; 2002.
  3. Facts and Figures on Cancer in the EU. Health-EU. The public health portal of the European Union. EUROSTAT, <http://ec.europa.eu/health-eu/health_problems/cancer/index_en.htm>.
  4. World Health Organization. Programmes and projects: Cancer, <http://www.who.int/cancer/en/>.
  5. Jensen OM, Estève J, Møller H, Renard H. Cancer in the European Community and its member states. Eur J Cancer. 1990;26:1167–1256
  6. Black RJ, Bray F, Ferlay J, Parkin DM. Cancer incidence and mortality in the European Union: cancer registry data and estimates of national incidence for 1990. Eur J Cancer. 1997;33:1075–1107
  7. Bray F, Sankila R, Ferlay J, Parkin DM. Estimates of cancer incidence and mortality in Europe in 1995. Eur J Cancer. 2002;38:99–166
  8. World Health Organization (WHO) Databank. Geneva, Switzerland: WHO Statistical Information System, <http://www.who.int/whosis> [accessed May 2009].
  9. Hospices Civils de Lyon/Institut de Veille Sanitaire/Institut National du Cancer/Francim/Institut National de la Santé et de la Recherche Médicale. Projections de l’incidence et de la mortalité par cancer en France pour l’année 2008. Rapport technique, http://www.invs.sante.fr/surveillance/cancers; Mars 2009 [accessed 17.06.09].
  10. United Nations, Population division. World Population Prospects, the 2006 revision, <http://www.un.org/> [accessed 08.11.08].
  11. ECO. European Cancer Observatory. Lyon: International Agency for Research on Cancer, <http://eu-cancer.iarc.fr>; 2009 [accessed 27.07.09].
  12. Ferlay J, Bray B, Pisani P, Parkin DM. GLOBOCAN 2002: cancer incidence, mortality and prevalence worldwide. IARC CancerBase No. 5. Version 2.0. Lyon: IARCPress; 2004.
  13. WHO International Statistical Classification of Diseases and Related Health Problems. Tenth Revision, vol. 2. Geneva, Switzerland: WHO; 1993.
  14. Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol. 2007;18:581–592
  15. Nordpred. A software for predicting trends in cancer incidence, <http://www.kreftregisteret.no/en/Research/Projects/Nordpred/> [accessed 17.12.08].
  16. Dyba T, Hakulinen T. Comparison of different approaches to incidence prediction based on simple interpolation techniques. Stat Med. 2000;19(13):1741–1752
  17. Doll R, Payne P, Waterhouse J, editors. Cancer incidence in five continents: A technical report. Berlin, Germany: Springer-Verlag (for UICC); 1966.
  18. Lutz JM, Pury P, Fioretta G, Raymond L. The impact of coding process on observed cancer mortality trends in Switzerland. Eur J Cancer Prev. 2004;13(1):77–81
  19. Loos AH, Bray F, McCarron P, Weiderpass E, Hakama M, Parkin DM. Sheep and goats: separating cervix and corpus uteri from imprecisely coded uterine cancer deaths, for studies of geographical and temporal variations in mortality. Eur J Cancer. 2004;40:2794–2803
  20. Sant M, Allemani C, Santaquilani M, Knijn A, Marchesi F, Capocaccia R. EUROCARE-4. Survival of cancer patients diagnosed in 1995–1999. Results and commentary, the EUROCARE Working Group. Eur J Cancer 2009;45:931–91.
  21. European Network of Cancer Registries. EUROCIM version 4.0. European mortality database V2.4 (2003), Lyon 2001.
  22. Jahrbuch der Gesundheit Statistik 2006. Wien: Statistic Austria; 2007.
  23. Cancer Incidence in Belgium, 2004–2005. Brussels: Belgian Cancer Registry, <http://www.kankerregister.org/>; 2008 [accessed 12.02.09].
  24. Bulgarian National Cancer Registry. National Oncological Hospital, <http://www.onco-bg.com/str/nrr.html>, [accessed 30.03.09].
  25. Croatian National Cancer Registry, Croatian National Institute of Public Health. Bulletins No. 28–30. Cancer incidence in Croatia 2003–2005. Zagreb: Croatian National Institute of Public Health; 2005–2007.
  26. Ministry of Health of the Republic of Cyprus – Health Monitoring – Statistics of Cancer – Cancer incidence data – Number of cases per cancer site, sex and year, 1998–2005, <http://www.moh.gov.cy> [accessed 06.05.09].
  27. Cancer incidence in the Czech Republic 2005. Institute of Health Information and Statistics of the Czech Republic in collaboration with National Cancer Registry of the Czech Republic, 2008, Prague. <http://www.uzis.cz> [accessed 28.04.09].
  28. The National Cancer Registry of Ireland, <http://www.ncri.ie/ncri/> [accessed 07.02.09].
  29. Capesius C, Scheiden R, Groff P, Golinska B, Juchem JP, Wehenkel Cl. Nouveaux cas de cancer au Luxembourg – Monographies des années 2003–2004–2005. Luxembourg: Registre Morphologique des Tumeurs au Grand – Duché de Luxembourg, <http://www.cancer-registry.lu>; 2007 [accessed 03.06.09].
  30. Malta National Cancer Registry. Malta: Department of Health Information, <http://www.sahha.gov.mt> [accessed 20.04.09].
  31. Dutch Comprehensive Cancer Centres. <http://www.iKCnet.nl> [accessed 16.09.08].
  32. Cancer incidence in the Slovak Republic 2004. Bratislava: Cancer Research Institute SAS, National Cancer Registry; 2008.
  33. Cancer Incidence in Slovenia 2005. Ljubljana: Institute of Oncology Ljubljana, Cancer Registry of Slovenia, 2008.
  34. Cancer in Ukraine 2005–2006. Kiev: Bulletin of National Cancer Registry of Ukraine, http://users.iptelecom.net.ua/~ucr/; 2007 [accessed 30.04.09].
  35. Gerda Engholm, Jacques Ferlay, Niels Christensen, Freddie Bray, Marianne L. Gjerstorff, Åsa Klint, Jóanis E. Køtlum, Elínborg Ólafsdóttir, Eero Pukkala, Hans H. Storm. NORDCAN: Cancer incidence, mortality and prevalence in the Nordic countries, version 3.4. Danish Cancer Society: Association of Nordic Cancer Registries; 2009 <http://www.ancr.nu>.
  36. The Office for National Statistics (ONS). Registrations of cancer diagnosed in 2006, England, <http://www.statistics.gov.uk> [accessed 31.03.09].
  37. ISD Cancer Information Programme, <http://www.isdscotland.org> [accessed 27.01.09].
  38. Welsh Cancer Intelligence and Surveillance Unit, <http://www.wales.nhs.uk> [accessed 28.03.09].
  39. Parkin DM, Whelan SL, Ferlay J, Storm H. Cancer incidence in five continents, vols. I–VIII. IARC Cancer Base no. 7. Lyon; 2005.
  40. Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, Boyle P, editors. Cancer incidence in five continents, vol. IX. IARC Scientific Publications no. 160. Lyon: IARC; 2008.
  41. Parkin DM, Bray F. Evaluation of data quality in the cancer registry: principles and methods Part II. Completeness. Eur J Cancer. 2009;45(5):756–764
  42. Karim-Kos HE, de Vries E, Soerjomataram I, Lemmens V, Siesling S, Coebergh JW. Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s. Eur J Cancer. 2008;44(10):1345–1389
  43. Gondos A, Bray F, Hakulinen T, Brenner H EUNICE Survival Working Group. Trends in cancer survival in 11 European populations from 1990 to 2009: a model-based analysis. Ann Oncol. 2009;20(3):564–573
  44. Percy C, Muir C. The international comparability of cancer mortality data. Results of an international death certificate study. Am J Epidemiol. 1989;129:934–946
  45. Mathers CD, Fat DM, Inoue M, Rao C, Lopez AD. Counting the dead and what they died from: an assessment of the global status of cause of death data. Bull World Health Organ. 2005;83(3):171–177
  46. Boyle P, Ferlay J. Cancer incidence and mortality in Europe, 2004. Ann Oncol. 2005;16(3):481–488
  47. Parkin DM. Is the recent fall in incidence of post-menopausal breast cancer in UK related to changes in use of hormone replacement therapy? Eur J Cancer 2009;45(9):1649–53.
  48. Bouchardy C, Usel M, Verkooijen HM, Fioretta G, Benhamou S, Neyroud-Caspar I, Schaffar R, Vlastos G, Wespi Y, Schäfer P, Rapiti E. Changing pattern of age-specific breast cancer incidence in the Swiss canton of Geneva. Breast Cancer Res Treat 2009.
  49. Bray F, McCarron P, Parkin DM. The changing global patterns of female breast cancer incidence and mortality. Breast Cancer Res. 2004;6(6):229–239
  50. Héry C, Ferlay J, Boniol M, Autier P. Quantification of changes in breast cancer incidence and mortality since 1990 in 35 countries with Caucasian-majority populations. Ann Oncol. 2008;19(6):1187
  51. Kvåle R, Auvinen A, Adami HO, Klint A, Hernes E, Møller B, et al. Interpreting trends in prostate cancer incidence and mortality in the five Nordic countries. J Natl Cancer Inst. 2007;99(24):1881–1887
  52. Bouchardy C, Fioretta G, Rapiti E, Verkooijen HM, Rapin CH, Schmidlin F, et al. Recent trends in prostate cancer mortality show a continuous decrease in several countries. Int J Cancer. 2008;123(2):421–429

PII: S0959-8049(09)00926-5

doi: 10.1016/j.ejca.2009.12.014

European Journal of Cancer
Volume 46, Issue 4 , Pages 765-781 , March 2010

Article Tools

* Image Usage & Resolution